Amelioration of muscle wasting by glucagon‐like peptide‐1 receptor agonist in muscle atrophy

BACKGROUND: Skeletal muscle atrophy is defined as a reduction of muscle mass caused by excessive protein degradation. However, the development of therapeutic interventions is still in an early stage. Although glucagon‐like peptide‐1 receptor (GLP‐1R) agonists, such as exendin‐4 (Ex‐4) and dulaglutid...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Yeonhee, Lee, Jong Han, Jeong, Kwang Won, Choi, Cheol Soo, Jun, Hee‐Sook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6711418/
https://www.ncbi.nlm.nih.gov/pubmed/31020810
http://dx.doi.org/10.1002/jcsm.12434

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6711418/
https://www.ncbi.nlm.nih.gov/pubmed/31020810
http://dx.doi.org/10.1002/jcsm.12434

Ejemplares similares